Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2014 - 2026)

Zimmer Biomet Holdings (ZBH) recorded quarterly Non-Current Deferred Tax Liability of $249.9 million in Q1 2026, up 2.38% quarter-over-quarter from $244.1 million in Q4 2025.

Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends

Zimmer Biomet Holdings' Non-Current Deferred Tax Liability history runs 13 years deep, the most recent figure standing at $249.9 million for Q1 2026.

  • In Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $249.9 million; the TTM figure through Mar 2026 stood at $249.9 million (changed N/A YoY), while the FY2025 annual figure was $244.1 million, down 30.75% from the prior year.
  • Non-Current Deferred Tax Liability was $249.9 million for Q1 2026 at Zimmer Biomet Holdings, up from $244.1 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $541.3 million in Q3 2022 to a low of $244.1 million in Q4 2025.
  • Historically, Non-Current Deferred Tax Liability has averaged $419.3 million across 5 years, with a median of $470.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability tumbled 35.99% in 2022, then retreated 1.12% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $474.8 million in 2022, then retreated by 24.68% to $357.6 million in 2023, then dropped by 1.43% to $352.5 million in 2024, then slumped by 30.75% to $244.1 million in 2025, then climbed by 2.38% to $249.9 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $249.9 million (Q1 2026), $244.1 million (Q4 2025), and $352.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn
10 Zimmer Biomet Holdings 17.27 Bn 16.86 Bn 1.51 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 249.90 Mn
Mar 31, 2026 249.90 Mn
Dec 31, 2025 244.10 Mn
Dec 31, 2025 244.10 Mn
Dec 31, 2024 352.50 Mn
Dec 31, 2024 352.50 Mn
Mar 31, 2024 370.40 Mn
Mar 31, 2024 370.40 Mn
Dec 31, 2023 357.60 Mn
Dec 31, 2023 357.60 Mn
Sep 30, 2023 465.40 Mn
Sep 30, 2023 465.40 Mn
Jun 30, 2023 474.90 Mn
Jun 30, 2023 474.90 Mn
Mar 31, 2023 484.60 Mn
Mar 31, 2023 484.60 Mn
Dec 31, 2022 474.80 Mn
Dec 31, 2022 474.80 Mn
Sep 30, 2022 541.30 Mn
Sep 30, 2022 541.30 Mn